Liu, Pei-Kang
Chi, Yi-Chun
Chang, Yo-Chen
Lin, Yi-Hsiung
Chen, Chi-Yu
Liu, Connie
Tyan, Yu-Chang
Chang, Kun-Che
Funding for this research was provided by:
NSTC (114-2314-B-037-115)
Kaohsiung Medical University Chung-Ho Memorial Hospital (113-3R45)
NIH (P30-EY008098)
Research to Prevent Blindness (unrestricted research grant)
Article History
Received: 14 August 2025
Accepted: 6 January 2026
First Online: 10 January 2026
Declarations
:
: This study used the human retinal pigment epithelial cell line ARPE-19 (ATCC CRL-2302). No human participants or live vertebrate animals were involved; therefore, institutional ethics approval and informed consent were not required. ARPE-19 cells were authenticated by the supplier and routinely tested to confirm absence of mycoplasma contamination. All procedures complied with institutional biosafety guidelines.
: The authors declare no competing interests.